Previous Article | Next Article 
Infection and Immunity, April 2001, p. 2339-2344, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2339-2344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunochemical and Biological Characterization of Three Capsular
Polysaccharides from a Single Bacteroides fragilis
Strain
Wiltrud M.
Kalka-Moll,1,*
Ying
Wang,1
L. E.
Comstock,1
Sylvia E.
Gonzalez,1
Arthur O.
Tzianabos,1 and
Dennis L.
Kasper1,2
Channing Laboratory, Department of Medicine,
Brigham and Women's Hospital,1 and
Department of Microbiology and Molecular
Genetics,2 Harvard Medical School, Boston,
Massachusetts 02115
Received 11 October 2000/Returned for modification 27 November
2000/Accepted 10 January 2001
 |
ABSTRACT |
Although Bacteroides fragilis accounts for only 0.5%
of the normal human colonic flora, it is the anaerobic species most
frequently isolated from intra-abdominal and other infections with an
intestinal source. The capsular polysaccharides of B. fragilis are part of a complex of surface polysaccharides and are
the organism's most important virulence factors in the formation of
intra-abdominal abscesses. Two capsular polysaccharides from strain
NCTC 9343, PS A1 and PS B1, have been characterized structurally. Their
most striking feature is a zwitterionic charge motif consisting of both
positively and negatively charged substituent groups on each repeating
unit. This zwitterionic motif is essential for abscess formation. In
this study, we sought to elucidate structural features of the capsular
polysaccharide complex of a commonly studied B. fragilis
strain, 638R, that is distinct from strain 9343. We sought a more
general picture of the species to establish basic structure-activity and structure-biosynthesis relationships among abscess-inducing polysaccharides. Strain 638R was found to have a capsular
polysaccharide complex from which three distinct carbohydrates could be
isolated by a complex purification procedure. Compositional and
immunochemical studies demonstrated a zwitterionic charge motif common
to all of the capsular polysaccharides that correlated with their
ability to induce experimental intra-abdominal abscesses. Of interest is the range of net charges of the isolated polysaccharides
from positive (PS C2) to balanced (PS A2) to negative (PS 3). Relationships among structural components of the zwitterionic polysaccharides and
their molecular biosynthesis loci were identified.
 |
INTRODUCTION |
Intra-abdominal infections present
serious clinical conditions that are difficult to treat, frequently
require surgical intervention, and often result in short-term and
long-term complications. Bacteroides fragilis accounts for
only 0.5% of the normal human colonic flora but is the anaerobic
bacterium most frequently isolated from clinical infections in the
abdominal cavity (9, 25). The capsular polysaccharides of
B. fragilis are the most important virulence factors
responsible for the formation of intra-abdominal abscesses by this
organism (17, 19).
The capsular polysaccharides of B. fragilis exist on the
organism's surface as part of a capsular polysaccharide complex (CPC). For the B. fragilis type strain, NCTC 9343, two
polysaccharides of the CPC, PS A1 and PS B1, have been elucidated
structurally (2, 31). The gene loci for biosynthesis of PS
A1, PS B1, and a third, structurally unknown, capsular polysaccharide,
PS C1, have recently been sequenced (3; M. J. Coyne, A. O. Tzianabos, B. E. Mallory, D. L. Kasper, and L. E. Comstock, submitted
for publication). The most striking feature of all of the B. fragilis polysaccharides characterized to date is the presence of
both positively and negatively charged substituent groups on each
repeating unit. This specific charge motif (zwitterionic) is essential
for the unique biological activity of this class of molecules
(13, 30), including promotion of the formation of
intra-abdominal abscesses (30).
Studies with monoclonal antibodies (MAb) and polyclonal antiserum have
demonstrated, however, that the capsular polysaccharides of B. fragilis are quite heterogeneous (15, 26, 28). The B. fragilis strain that has been best studied, 638R, is
known to produce a CPC that is immunologically distinct from the CPC of
the type strain, NCTC 9343 (3, 21, 23, 27). However, the
polysaccharides composing the 638R CPC have not been characterized. The
biosynthesis loci of PS C from strain NCTC 9343 (PS C1) and strain 638R
(PS C2) were the first loci to be cloned and sequenced. These loci are
flanked by genes common to both strains; however, the genes involved in
polysaccharide biosynthesis are distinct (3-5).
In this study, we sought to elucidate structural features of the
B. fragilis strain 638R CPC to develop a clearer picture of
the diversity of polysaccharides in the species and of the basic
structure-activity and structure-biosynthesis relationships of
abscess-inducing polysaccharides. To our knowledge, this is the first
report of the isolation of three different surface-expressed capsular
polysaccharides
PS A2, PS C2, and PS 3
from one bacterial strain. The
immunochemical characteristics and abscess-inducing potentials of these
capsular polysaccharides are described and brought together with
information about their biosynthetic pathways.
 |
MATERIALS AND METHODS |
Bacterial strain and isolation of capsular polysaccharides of
B. fragilis strain 638R.
B. fragilis strain
638R (27) was maintained in peptone-yeast broth at
80°C. The production of CPC was enhanced and the glycogen content
in extracts was minimized by the serial passage of bacteria five times
through rat spleens (male Wistar rats; 175 to 200 g; Charles River
Laboratories, Wilmington, Mass.) (14). Initially,
108 organisms in phosphate-buffered saline (PBS) were
injected intraperitoneally into a rat and recovered 24 h later by
dispersing the spleen. The organisms were cultured overnight
anaerobically on brucella agar with 5% sheep blood (PML
Microbiologicals, Mississauga, Ontario, Canada). The inoculation and
recovery processes were repeated. Enhanced production of capsule was
confirmed by electron microscopy studies with polyvalent antiserum to
whole bacteria (data not shown). After the passages, the bacteria were
grown anaerobically in a 16-liter batch culture as described previously
(22, 31). The cells were harvested by centrifugation
(average wet weight, 244 g) and suspended in water. CPC was extracted
from the bacterial cells with hot phenol-water and digested extensively
with RNase, DNase, and pronase. The dialyzed product (average dry
weight, 2 g) was chromatographed on a column of Sephracyl S-400 HR
(Amersham Pharmacia Biotech, Piscataway, N.J.) in a 3% deoxycholate
acid-containing buffer at pH 9.8 to separate lipopolysaccharide (LPS)
from CPC (22, 31). Chromatographic fractions were analyzed
throughout the isolation procedure by measurements of UV absorbance at
280, 260, and 206 nm; refractive index; and protein by the
bicinchoninic acid method (Pierce, Rockford, Ill.), silver staining of
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (16), dot blot assay, immunoelectrophoresis (IEP),
and immunodiffusion (20, 22). After gel filtration
chromatography with S-400 HR, silver-stained SDS-PAGE showed fractions
with a high-molecular-mass antigen (>160 kDa according to protein
standards) representing CPC. Subsequently eluted fractions showed
antigens smaller than 20 kDa at the gel front that represented LPS and digested protein and nucleic acid. Fractions eluted between CPC and LPS
contained both materials. Fractions containing capsular polysaccharide
exclusively and reacting with antiserum to the whole bacteria by double
immunodiffusion were pooled, concentrated, alcohol precipitated,
dialyzed, and lyophilized. The CPC (average dry weight, 0.2 g) was
examined by IEP (in 50 mM Tris buffer at pH 7.3), which showed three
dominant components, two positively and one negatively charged, and two
weak, distinct components migrating towards the anode and cathode (Fig.
1).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
IEP of the CPC and separated, purified polysaccharide
components PS 1, PS 2, and PS 3 of the capsule of B. fragilis strain 638R at different pH values. Each antigen
preparation was reacted with polyvalent rabbit anti-B.
fragilis strain 638R antiserum.
|
|
Acid-treated (5% acetic acid at 100°C for 1 h), dialyzed, and
lyophilized CPC was loaded onto a column containing Q-Sepharose FF
(Amersham Pharmacia Biotech) in 50 mM Tris buffer at pH 7.3. Antigens
were eluted with Tris buffer and an NaCl gradient (Fig. 2). Further purification steps required
anion-exchange chromatography with S-Sepharose (Amersham Pharmacia
Biotech) in water at pH 4, Q-Sepharose FF in 50 mM Tris buffer at pH
8.6, gel-filtration chromatography with Sephracyl S-300 HR (Amersham
Pharmacia Biotech) in 50 mM PBS at pH 7.3, and isoelectric focusing.
Separated polymers maintained their reactivity with the polyclonal
antiserum. Fractions that appeared identical by the different
measurements were pooled, dialyzed, lyophilized, and analyzed by
high-resolution (500-MHz) proton nuclear magnetic resonance (NMR)
spectroscopy. The final product was found to be essentially free of
contaminating protein, nucleic acid, LPS, and lipids (29).
The capsular polysaccharides were prepared in sterile, pyrogen-free
saline for administration to animals.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Recorded profile of UV absorbance at 280 nm, refractive
index (RI), and conductivity (cond) of ion-exchange chromatography
(Q-Sepharose FF) of the capsular polysaccharide complex of B. fragilis strain 638R with 50 mM Tris (pH 7.3) (A) and during
elution with an NaCl gradient (B). The polysaccharide-containing
fractions were identified by dot blot assay, IEP, immunodiffusion, and
NMR.
|
|
Chemical characterization of capsular polysaccharides.
Polysaccharides were analyzed for monosaccharide constituents and
structure by both gas chromatography-mass spectroscopy (GC-MS) and NMR,
as described elsewhere (32, 34). For GC-MS analysis, the
polysaccharides were hydrolyzed completely and converted to alditol
acetate derivatives. Analyses were performed on an HP 6890/5973 GC-MS
spectrometer (Hewlett Packard, Wilmington, Del.) with a capillary DB17
column (J&W Scientific, Folsom, Calif.). GC was started at 150°C and
held for 2 min; after an increase to 260°C at a rate of 5°C/min, GC
was held at the final temperature for 20 min. Mass detection was
obtained by electron ionization at 70 eV, and ions were scanned from 45 to 550 m/z. NMR experiments were performed on a Unity 500 spectrometer (Varian, Palo Alto, Calif.) with a proton resonance
frequency of 500 MHz. All 1H spectra were recorded at
70°C in 2H2O, and chemical shifts were
referenced in relation to H2HO resonance at 4.36 ppm. The
molecular-size distribution of the polysaccharides was determined by
gel filtration chromatography on Superose 6 columns calibrated with
dextran standards according to the fractionation ranges of the gel
(Amersham Pharmacia Biotech) at a flow rate of 0.5 ml/min (13,
24, 33).
Preparation of polyclonal antiserum.
Antiserum to B. fragilis strain 638R was prepared by intravenous immunization of
New Zealand White rabbits three times a week for 3 weeks followed by a
single booster injection during the fifth week and bleeding after 7 weeks. Each injection consisted of ~109 bacteria that
were grown in basal medium, killed with formalin, and resuspended in 1 ml of sterile saline.
Immunological assays.
Double diffusion in agarose was
performed by the method of Ouchterlony (20) with 1%
agarose in 50 mM Tris (pH 7.3). IEP was performed in 1% agarose in 50 mM Tris (pH 7.3), 50 mM phosphate buffer (pH 6.2), and 0.2 M barbital
buffer (pH 8.6). The polysaccharide antigens were used as 1-mg/ml
solutions. Each antigen preparation was reacted with polyvalent rabbit
anti-B. fragilis strain 638R antiserum (10).
SDS-PAGE was performed according to the method of Laemmli
(16) with 4 to 20% gradient gels. The gels were stained with silver stain (Bio-Rad, Hercules, Calif.). Dot blotting was performed by applying 2.5 µl of capsular polysaccharide from a 1-mg/ml solution to a nitrocellulose paper as described previously (22).
For pooled chromatography fractions and purified polysaccharides, an
enzyme-linked immunosorbent assay (ELISA) with and without inhibition
was performed as described previously (11, 21). In brief,
polystyrene microtiter plates (Immulon A; Dynatech Laboratories, Chantilly, Va.) were coated with poly-L-lysine-coupled
polysaccharides. After nonspecific binding was blocked, polyvalent
rabbit anti-B. fragilis strain 638R antiserum, MAb 4D5
(21), or control antibody with or without B. fragilis strain 638R polysaccharides was added. The reactions were
visualized with an alkaline phosphatase-conjugated anti-rabbit or
anti-mouse polyclonal antibody (Sigma, St. Louis, Mo.) and by
subsequent addition of the phosphatase substrate
p-nitrophenyl phosphate (Sigma).
For the electron microscopic visualization of the capsules of bacterial
cells, bacteria were grown as described above, washed extensively, and
suspended in 15 mM PBS. Drops of bacterial solutions (5 µl) were
placed on Parafilm, and 200-mesh Formvar-carbon-coated copper grids
(Electron Microscopy Sciences, Fort Washington, Mass.) were placed on
top of the drops for 1 min. The grids were then blocked by placement on
a 15-µl drop of 0.5% fish skin gelatin in 15 mM PBS with 0.1% Tween
20. Application of the primary antibody, polyvalent rabbit antiserum to
B. fragilis strain 638R diluted 1:1,000 in blocking buffer,
with or without inhibiting capsular polysaccharide, to the grids in a
fashion similar to that described above was followed by incubation for
20 min at room temperature and four washes with 15 mM PBS. Normal
rabbit serum, mouse serum, or isotype-matched antibodies were used as
controls. Gold-conjugated protein A (with gold particles 20 nm in
diameter) was applied at a dilution of 1:20 in blocking buffer. After
the grids were incubated for 15 min at room temperature, they were
washed twice with 15 mM PBS and deionized water. Staining was performed
in quadruplicate. The grids were examined by an observer unaware of the
experimental design. Two hundred bacteria on each grid were counted,
and the number of gold-labeled bacteria was recorded. The inhibition of
labeling was expressed as a percentage.
Isolation of capsular polysaccharide PS A1 from B. fragilis NCTC 9343.
PS A1 from B. fragilis NCTC
9343 was prepared as described previously (2, 22, 30, 31).
The polysaccharide was isolated by hot phenol-water extraction, enzyme
digestion, gel filtration, and anion-exchange chromatography, and
isoelectric focusing. PS A1 was prepared in sterile, pyrogen-free
saline for administration to animals.
Animal model for abscess induction.
In two independent
experiments, 0.5 ml of injection volume containing 100, 10, 1, or 0.1 µg of capsular polysaccharide and sterile cecal contents (dilution,
1:4 in PBS) was administered intraperitoneally by injection through an
18-gauge needle to groups of six outbred male Wistar rats (150 to
175 g; Charles River Laboratories). As the control, PBS was
substituted for the capsular polysaccharide. Six days after challenge,
the rats were sacrificed and then examined for macroscopically visible
intraperitoneal abscesses by observers unaware of the treatment status.
Grossly visible abscesses were confirmed microscopically. The
development of one or more abscesses was considered a positive result.
Statistical analysis.
In vivo experiments were analyzed in a
structured logistic regression model that permitted evaluation of
separate dose-response relationships (dose in micrograms) and direct
interference on the median abscess inducing dose (AD50),
which is the theoretical dose of polysaccharide required to induce
abscesses in 50% of animals (6, 13, 30). Likelihood ratio
tests were performed for hypotheses concerning commonality of
dose-response slopes and AD50s. Rats that died within 2 days after challenge were not included in the analysis because their
deaths were due to anesthesia.
 |
RESULTS |
Isolation of polysaccharides.
Attempts to separate the
differently charged polymers by isoelectric focusing or application of
ion-exchange or gel filtration chromatography were not successful,
whereas mild acid hydrolysis and further processing by ion-exchange and
gel filtration chromatography and isoelectric focusing led to the
isolation of distinct capsular polysaccharides.
The flow of the Q-column run yielded a purified polysaccharide that was
temporarily designated PS 1 (average molecular mass, 110 kDa). A
distinct polysaccharide, termed PS 2, also eluted from this column, but
the preparation was contaminated with PS 1 (Fig. 2A). In addition,
fractions that eluted with a low NaCl concentration (conductivity, 22 µS/cm) yielded a third polysaccharide, designated PS 3, which was
also contaminated with PS 1 (Fig. 2B).
Further processing of the fractions containing PS 2 by chromatography
using S-300 HR and 2 M NaCl elution of S-Sepharose FF (distilled
H2O [pH 4]) permitted purification of PS 2. PS 2 was found to have an average molecular mass of 250 kDa.
Separation of PS 3 from PS 1 was achieved by chromatography with
Q-Sepharose FF (50 mM Tris at pH 8.6 and 5% octyl-
-glucoside [Pierce]). PS 3 (average molecular mass, 185 kDa) was eluted with a
low concentration of salt (conductivity, 29.5 µS/cm). After dialysis,
PS 3 was purified by isoelectric focusing with a pH gradient of 3 to 10 in 1% ampholyte (Bio-Lyte; Bio-Rad), where it migrated at pH 3 toward
the anode.
Immunochemical characterization of polysaccharides.
IEP of the
isolated polysaccharides at acid, neutral, and basic pHs showed
distinct patterns reflecting different structural compositions and net
charge motifs. The distinct patterns represented the main components of
the CPC described above (Fig. 1).
PS 1 showed a predominant neutral-to-positive charge motif at neutral
pH that was unchanged at pH 6.2 and slightly shifted toward the anode
at pH 8.6. Efforts to determine the exact isoelectric point of PS 1 by
isoelectric focusing showed a wide distribution over a pH range between
4.5 and 10 (data not shown). However, the structure and conformation of
PS 1, as determined by a combination of various analyses, showed a
polymer with one free amino group and one carboxyl group per repeating
unit, properties that give the polymer an average net neutral charge
motif and classify it as a balanced zwitterionic polysaccharide
(34). PS 1 is composed of five residues, namely,
2-amino-4-acetamido-2,4,6-trideoxygalactose (AAT), fucose (Fuc),
mannoheptose (Hep) replaced with 3-hydroxybutanoic acid,
N-acetylmannosamine (ManNAc), and
3-acetamido-3,6-dideoxyglucose (ADG) (GC-MS analysis [Table
1]). NMR spectroscopy confirmed five anomeric proton signals at 5.26, 4.97, 4.84, 4.79, and 4.70 ppm
(Fig. 3). Further studies by
two-dimensional NMR spectroscopies, chemical methods,
gas chromatography, and molecular modeling elucidated both the chemical and three-dimensional structures described
elsewhere (34). The repeating unit of PS 1 is a
branched pentasaccharide with the sequence of
2-Hep-(1
3)-ManNAc-(1
4)[Fuc-(1
2)]-ADG-(1
3)-AAT-(1
.
On the basis of the structure of PS 1 and a partial analysis of the
biosynthesis region in the same area of the 638R chromosome that
encodes PS A1 of NCTC 9343, PS 1 was redesignated PS A2 (Coyne et al.,
submitted). PS A2 was reactive with polyclonal antiserum to whole
bacteria. In an inhibition ELISA, polyclonal antiserum adsorbed with PS
A2 (25 µg/ml) showed a dose-dependent reduction of up to 100% of
reactivity with PS A2. A dose of 0.06 µg/ml inhibited the reaction by
50% (Fig. 4). The reactivity of
polyclonal antiserum with whole organisms in electron microscopy was
reduced by an average of 52% by adsorption with the purified PS A2.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Inhibition by PS A2 and PS C2 of binding of rabbit
polyclonal antiserum raised to whole bacteria of B. fragilis
strain 638R on microtiter wells coated with PS A2. The values are the
means of duplicate determinations.
|
|
Electrophoretic mobility suggested that a PS 2 molecule has a net
positive charge (Fig. 1). Both GC-MS analysis and NMR indicated that PS
2 is slightly contaminated
predominantly with PS 1. Unfortunately, we
could not completely separate PS 2 from this polysaccharide because of
the limited quantity of PS 2 synthesized by the bacterial strain
(purified amount, 5 mg). Adsorption of polyclonal antiserum with PS 2 reduced immunolabeling in electron microscopy by an average of 15%.
However, by subtractive analysis, we were able to determine the
composition of PS 2, which is definitely distinct from the other two
sugars: GC-MS analysis identified pentose, mannose, fucosamine, an
unidentified amino sugar, and uronic acids of 2-amino-6-dideoxyhexose
and of hexosamine (Table 1). NMR analysis showed structural differences
between PS 2 and both PS 1 and PS 3. These differences were most
evident from the proton chemical shifts between 4.5 and 5.5 ppm. PS 2 showed several acetyl signals around 2.05 ppm, indicating that PS C2
has several N- or O-acetylated hexosamines. Resonances at ~1.3
ppm arise from methyl groups of 6-deoxy sugars (Fig. 3).
A polysaccharide biosynthesis locus involved in the synthesis of an
unidentified polysaccharide of NCTC 9343 was sequenced. Because this
locus was shown not to be involved in the synthesis of PS A1 or PS B1,
it was designated the PS C1 biosynthesis locus. The same area of the
638R chromosome was sequenced and was similarly designated the PS C2
biosynthesis locus because the genes involved in polysaccharide
biosynthesis were distinct from those of the PS C1 locus
(5). A mutant with a transposon in the PS C2 locus was
unable to produce the capsular polysaccharide that reacts with MAb
4D5. We have demonstrated that among our collection of 50 B. fragilis strains, only those with a PS C locus genetically similar
to 638R react with 4D5, indicating that this MAb is specific for PS C2.
PS 2 was demonstrated by dot blot assay, double immunodiffusion, IEP,
and ELISA to be reactive with MAb 4D5 and was therefore designated PS
C2. Based on the genetic complement of the PS C2 locus, the composing
sugars were predictive. Inhibition ELISA with polyclonal antiserum and
PS A2 and PS C2 as inhibitors showed a 10-fold difference in inhibition
between the two polysaccharides. PS C2 inhibited the reactivity of the
PAS with PS A2 by 50% at a theoretical dose of 0.6 µg/ml (Fig. 4).
Because neither biosynthesis nor a flanking region has been identified
for the third isolated polysaccharide, for the time being this polymer
is called PS 3. The net charge of PS 3 is negative, as shown by IEP
(Fig. 1), and its behavior during the purification process by
ion-exchange chromatography predicted a negatively charged polymer
(Fig. 2). GC-MS analysis identified galactose, mannosamine,
rhamnose, and three uronic acids, one of a 6-deoxyhexosamine and
two of hexosamines (Table 1). NMR spectroscopy showed resonances between 4.5 and 5.5 ppm from six anomeric carbons and chemical-shift signals around 1.3 ppm originating from sugars, such as rhamnose and
3-acetamido-3,6-dideoxyglucose (Fig. 3). Adsorption of the polyclonal
antiserum with PS 3 reduced immunolabeling of whole bacteria by an
average of 41% in electron microscopy.
Biological activity of polysaccharides in experimental abscess
formation.
All the polysaccharides in the tested dose ranges
induced intra-abdominal abscesses in a dose-dependent fashion (testing
for no dose effect; PS A1, PS A2, and PS 3, P < 0.001;
PS C2, P = 0.19) (Fig.
5). PS A1 of B. fragilis NCTC
9343 was the most potent abscess-inducing zwitterionic polysaccharide,
with an AD50 of 0.28 µg. The AD50 of the
zwitterionic polysaccharide PS A2 of strain 638R was 4.79 µg
17
times higher. At a theoretical dose of 3.58 µg, the predominantly negatively charged polysaccharide PS 3 would have induced abscesses in
50% of the animals. The AD50 of the predominantly
positively charged polysaccharide PS C2 was 749.89 µg.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 5.
Induction of intra-abdominal abscesses in rats with
different doses of capsular polysaccharides PS A2, PS C2, and PS 3 of
B. fragilis strain 638R, PS A1 of B. fragilis NCTC 9343, and saline. The rat model of
intra-abdominal-abscess formation was used in two independent
experiments with six rats per group in each experiment.
|
|
 |
DISCUSSION |
Studies with monoclonal and polyclonal antibodies have
demonstrated that capsular polysaccharides of abscess-inducing B. fragilis strains, including the type strain, NCTC 9343, and the
clinical strain 638R, are heterogeneous (3, 15, 21, 23,
26-28). For strain NCTC 9343, two polysaccharides of a CPC have
been fully characterized (2, 31). Only a few bacterial
organisms are known to produce such a complicated array of surface
polysaccharides (1, 8, 12, 18). Recently, three
polysaccharide biosynthesis loci have been identified for the strain
NCTC 9343 (7; Coyne et al., submitted). In this study, we were able to
isolate three different immunogenic capsular polysaccharides of the
strain 638R.
Although the biological activity of PS A2 in vivo is very high, it is
nevertheless 17 times lower than that of PS A1. Both polysaccharides
have a balanced positive and negative charge motif on each repeating
unit, and they have comparable molecular masses. However, several
aspects of their three-dimensional structures might be different.
Conformational modeling of PS A2 suggested a right-handed helix with
two repeating units per turn and a pitch of 20 Å (34).
Exposure of positive and negative charges on the outer surface of the
polymer in a regularly spaced pattern renders them accessible to other
molecules. In contrast to PS A2, PS A1 consists of only a
tetrasaccharide instead of a pentasaccharide repeating unit, a
difference that might contribute to a smaller pitch (31).
The genes wcfR and wcfS are involved in the
synthesis of the unusual sugar AAT and are found in the PS A1 locus of
strain 9343 and in the PS A2 locus of strain 638R (Coyne et al.,
submitted). Although PS A1 and PS A2 have the
-D-AAT
sugar in common, the amino group is at position 2 in PS A2 and at
position 4 in PS A1. This and other compositional differences might
lead to different charge accessibilities, to different configurations
of large grooves, to a slightly more preferred configuration of PS A1
that enhances the interaction between polysaccharides and protein
molecules required for biological activity (13), and to an
altogether different host response. Another explanation for the lower
abscess-inducing activity of PS A2 might be that, although PS A2
demonstrated an average balanced zwitterionic charge motif, isoelectric
focusing showed that PS A2, in contrast to PS A1, had a heterogeneous
charge distribution ranging from a negative to a positive net charged motif. This heterogeneity may indicate that PS A2 is being isolated in
a form with molecules having variable degrees of acetylation.
The PS C2 biosynthesis locus has been sequenced and found to be
composed of 22 open reading frames (3). Two genes encoding products similar to aminotransferases were identified, suggesting that
PS C2 contains at least two monosaccharides with free amino groups.
This finding was confirmed by the results of the GC-MS analysis, NMR,
and IEP. Complementation analysis has determined that the products of
two genes, mnaA and mnaB (formerly
wcgC and wcgD), are involved in the synthesis of
N-acetyl-mannosaminuronic acid, which could be the uronic
acid of hexosamine identified by GC-MS analysis. Three clustered genes,
wcgJ to wcgL, encode products likely to be
involved in the formation of N-acetylfucosamine. A possibly
N-acetylated form of a fucosamine was identified by GC-MS analysis.
Homology-based analysis identified five putative glycosyltransferases,
suggesting that PS C2 contains at least five monosaccharides
(3). GC-MS analysis identified six composing sugars. The
AD50 of PS C2, at 749.89 µg, was unexpectedly high.
C-substance, the group polysaccharide from Streptococcus
pneumoniae, is another naturally occuring zwitterionic
polysaccharide with a positive net charge. It has a tetrasaccharide
repeating unit with a total of three positive and two negative charges,
which give a highly charged density to the polysaccharide. C-substance
was shown to be a potent abscess-inducing polymer with an
AD50 of 5 µg (30). We hypothesize that
contaminating polysaccharides isolated with PS C2 may be masking
critical charges and configurations, resulting in a loss of
abscess-inducing potency.
PS 3 was shown by GC-MS analysis to contain three sugars carrying
uronic acids, to possess a net negative zwitterionic charge motif
demonstrated by IEP, and to be a potent abscess-inducing capsular
polysaccharide. We were not able to determine by GC-MS analysis which
of the hexosamines is N acetylated. PS 3 certainly has a high density
of charged molecules, which renders the polysaccharide very capable of
inducing intra-abdominal abscesses. Previously, the capsular
polysaccharide of S. pneumoniae type 1 was shown to induce
intra-abdominal abscesses in 50% of animals at a dose of 31 µg, and
PS B1 of B. fragilis NCTC 9343 had an AD50 of 25 µg. Both of these capsular polysaccharides carry two negatively changed groups and one positively charged group per repeating unit
(30).
We were able to isolate three distinct surface-expressed capsular
polysaccharides from a single abscess-modulating bacterial strain,
B. fragilis 638R. Compositional and immunochemical studies demonstrated a common zwitterionic charge motif in all of the capsular
polysaccharides, with net charges ranging from predominantly positive
to balanced to predominantly negative. This study reflects the
importance of the determination of the structural composition of the
CPC in a species in yielding information about biological activity,
biosynthesis, and their relationships.
 |
ACKNOWLEDGMENTS |
This work was supported in part by grants AI 34073 and AI 39576 from the National Institute of Allergy and Infectious Diseases.
We are grateful to Vincent J. Carey for statistical analysis and
to Nancy K. Voynow for editorial services.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Channing
Laboratory, 181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-2685. Fax: (617) 731-1541. E-mail:
wkalka-moll{at}rics.bwh.harvard.edu.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Abe, M.,
J. E. Sherwood,
R. I. Hollingsworth, and F. B. Dazzo.
1984.
Stimulation of clover root hair infection by lectin-binding oligosaccharides from the capsular and extracellular polysaccharides of Rhizobium trifolii.
J. Bacteriol.
160:517-520[Abstract/Free Full Text].
|
| 2.
|
Baumann, H.,
A. O. Tzianabos,
J. R. Brisson,
D. L. Kasper, and H. J. Jennings.
1992.
Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy.
Biochemistry
31:4081-4089[CrossRef][Medline].
|
| 3.
|
Comstock, L. E.,
M. J. Coyne,
A. O. Tzianabos, and D. L. Kasper.
1999.
Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R.
J. Bacteriol.
181:6192-6196[Abstract/Free Full Text].
|
| 4.
|
Comstock, L. E.,
M. J. Coyne,
A. O. Tzianabos,
A. Pantosti,
A. B. Onderdonk, and D. L. Kasper.
1999.
Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis.
Infect. Immun.
67:3525-3532[Abstract/Free Full Text].
|
| 5.
|
Comstock, L. E.,
A. Pantosti, and D. L. Kasper.
2000.
Genetic diversity of the capsular polysaccharide C biosynthesis region of Bacteroides fragilis.
Infect. Immun.
68:6182-6188[Abstract/Free Full Text].
|
| 6.
|
Cox, C.
1990.
Fieller's theorem, the likelihood and the delta method.
Biometrics
46:709-718[CrossRef].
|
| 7.
|
Coyne, M. J.,
W. Kalka-Moll,
A. O. Tzianabos,
D. L. Kasper, and L. E. Comstock.
2000.
Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci.
Infect. Immun.
68:6176-6181[Abstract/Free Full Text].
|
| 8.
|
Glazebrook, J., and G. C. Walker.
1989.
A novel exopolysaccharide can function in place of the calcofluor-binding exopolysaccharide in nodulation of alfalfa by Rhizobium meliloti.
Cell
56:661-672[CrossRef][Medline].
|
| 9.
|
Gorbach, S. L., and J. G. Bartlett.
1974.
Anaerobic infections (second of three parts).
N. Engl. J. Med.
290:1237-1245.
|
| 10.
|
Graber, P., and C. A. Williams.
1953.
Methode permettant l'etude conjuguee des proprietes electrophoretiques et immunochemiques d'un melange de proteins. Application au serum sanguin.
Biochim. Biophys. Acta
10:193[Medline].
|
| 11.
|
Gray, B. M.
1979.
ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.
J. Immunol. Methods
28:187-192[CrossRef][Medline].
|
| 12.
|
Gray, J. X., and B. G. Rolfe.
1990.
Exopolysaccharide production in Rhizobium and its role in invasion.
Mol. Microbiol.
4:1425-1431[CrossRef][Medline].
|
| 13.
|
Kalka-Moll, W. M.,
A. O. Tzianabos,
Y. Wang,
V. J. Carey,
R. W. Finberg,
A. B. Onderdonk, and D. L. Kasper.
2000.
Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
J. Immunol.
164:719-724[Abstract/Free Full Text].
|
| 14.
|
Kasper, D. L.,
A. B. Onderdonk,
B. G. Reinap, and A. A. Linberg.
1980.
Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
J. Infect. Dis.
142:750-756[Medline].
|
| 15.
|
Kasper, D. L.,
A. Weintraub,
A. A. Lindberg, and J. Lonngren.
1983.
Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.
J. Bacteriol.
153:991-997[Abstract/Free Full Text].
|
| 16.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 17.
|
Lindberg, A. A.,
A. Weintraub,
D. L. Kasper, and J. Lonngren.
1982.
Virulence factors in infections with Bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide.
Scand. J. Infect. Dis. Suppl.
35:45-52[Medline].
|
| 18.
|
Omar, A. S.,
J. Weckesser, and H. Mayer.
1983.
Different polysaccharides in the external layers (capsule and slime) of the cell envelope of Rhodopseudomonas capsulata Sp11.
Arch. Microbiol.
136:291-296[CrossRef][Medline].
|
| 19.
|
Onderdonk, A. B.,
D. L. Kasper,
R. L. Cisneros, and J. G. Bartlett.
1977.
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
J. Infect. Dis.
136:82-89[Medline].
|
| 20.
|
Ouchterlony, O.
1958.
Diffusion-in-gel methods for immunological analysis.
Prog. Allergy.
5:1-78.
|
| 21.
|
Pantosti, A.,
R. Colangeli,
A. O. Tzianabos, and D. L. Kasper.
1995.
Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
J. Clin. Microbiol.
33:2647-2652[Abstract].
|
| 22.
|
Pantosti, A.,
A. O. Tzianabos,
A. B. Onderdonk, and D. L. Kasper.
1991.
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.
Infect. Immun.
59:2075-2082[Abstract/Free Full Text].
|
| 23.
|
Pantosti, A.,
A. O. Tzianabos,
B. G. Reinap,
A. B. Onderdonk, and D. L. Kasper.
1993.
Bacteroides fragilis strains express multiple capsular polysaccharides.
J. Clin. Microbiol.
31:1850-1855[Abstract/Free Full Text].
|
| 24.
|
Paoletti, L. C., and K. D. Johnson.
1995.
Purification of preparative quantities of group B streptococcus type III oligosaccharides.
J. Chromatogr. A
705:363-368[CrossRef][Medline].
|
| 25.
|
Polk, B. F., and D. L. Kasper.
1977.
Bacteroides fragilis subspecies in clinical isolates.
Ann. Intern. Med.
86:569-571.
|
| 26.
|
Poxton, I. R., and R. Brown.
1986.
Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
J. Gen. Microbiol.
132:2475-2481[Medline].
|
| 27.
|
Privitera, G.,
A. Dublanchet, and M. Sebald.
1979.
Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
J. Infect. Dis.
139:97-101[Medline].
|
| 28.
|
Reid, J. H.,
S. Patrick, and S. Tabaqchali.
1987.
Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
J. Gen. Microbiol.
133:171-179[Medline].
|
| 29.
|
Tzianabos, A. O.,
R. W. Finberg,
Y. Wang,
M. Chan,
A. B. Onderdonk,
H. J. Jennings, and D. L. Kasper.
2000.
T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria.
J. Biol. Chem.
275:6733-6740[Abstract/Free Full Text].
|
| 30.
|
Tzianabos, A. O.,
A. B. Onderdonk,
B. Rosner,
R. L. Cisneros, and D. L. Kasper.
1993.
Structural features of polysaccharides that induce intra-abdominal abscesses.
Science
262:416-419[Abstract/Free Full Text].
|
| 31.
|
Tzianabos, A. O.,
A. Pantosti,
H. Baumann,
J. R. Brisson,
H. J. Jennings, and D. L. Kasper.
1992.
The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.
J. Biol. Chem.
267:18230-18235[Abstract/Free Full Text].
|
| 32.
|
Wang, Y., and R. I. Hollingsworth.
1994.
The structure of the O-antigenic chain of the lipopolysaccharide of Rhizobium trifolii 4s.
Carbohydr. Res.
260:305-317[CrossRef][Medline].
|
| 33.
|
Wang, Y.,
R. I. Hollingsworth, and D. L. Kasper.
1998.
Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages.
Proc. Natl. Acad. Sci. USA
95:6584-6589[Abstract/Free Full Text].
|
| 34.
|
Wang, Y.,
W. M. Kalka-Moll,
M. H. Roehrl, and D. L. Kasper.
2000.
Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis.
Proc. Natl. Acad. Sci. USA
97:13478-13483[Abstract/Free Full Text].
|
Infection and Immunity, April 2001, p. 2339-2344, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2339-2344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wexler, H. M.
(2007). Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin. Microbiol. Rev.
20: 593-621
[Abstract]
[Full Text]
-
Stephen, T. L., Niemeyer, M., Tzianabos, A. O., Kroenke, M., Kasper, D. L., Kalka-Moll, W. M.
(2005). Effect of B7-2 and CD40 Signals from Activated Antigen-Presenting Cells on the Ability of Zwitterionic Polysaccharides To Induce T-Cell Stimulation. Infect. Immun.
73: 2184-2189
[Abstract]
[Full Text]
-
Brigham, C. J., Malamy, M. H.
(2005). Characterization of the RokA and HexA Broad-Substrate-Specificity Hexokinases from Bacteroides fragilis and Their Role in Hexose and N-Acetylglucosamine Utilization. J. Bacteriol.
187: 890-901
[Abstract]
[Full Text]
-
Zhang, G., Dai, J., Lu, Z., Dunaway-Mariano, D.
(2003). The Phosphonopyruvate Decarboxylase from Bacteroides fragilis. J. Biol. Chem.
278: 41302-41308
[Abstract]
[Full Text]
-
Kalka-Moll, W. M., Tzianabos, A. O., Bryant, P. W., Niemeyer, M., Ploegh, H. L., Kasper, D. L.
(2002). Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions. J. Immunol.
169: 6149-6153
[Abstract]
[Full Text]